Vaxxa AB (NGM:VAXXA)

Vaxxa AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27	42	25	13	24	10
Market Cap Growth	-43.94%	67.53%	95.17%	-45.22%	144.50%	106.13%
Enterprise Value	18	35	23	12	22	10
Last Close Price	0.62	1.14	1.10	7.10	39.40	57.00
PE Ratio	-	109.38	-	-	-	-
PS Ratio	0.39	0.53	0.47	-	4.99	16.14
PB Ratio	1.24	2.15	2.52	0.92	2.41	0.89
P/TBV Ratio	1.49	2.90	7.19	0.92	4.28	0.89
EV/Sales Ratio	0.27	0.44	0.44	-	4.71	16.09
EV/EBITDA Ratio	-	15.03	-	1.48	-	-
EV/EBIT Ratio	-	118.24	-	-	-	-
Debt / Equity Ratio	0.03	0.02	0.04	-	-	-
Debt / EBITDA Ratio	-	0.20	-	-	-	-
Asset Turnover	2.86	3.49	3.03	-	0.40	0.08
Quick Ratio	5.27	2.08	0.99	1.00	4.23	5.04
Current Ratio	5.91	2.10	1.01	1.02	4.33	5.26
Return on Equity (ROE)	-17.30%	2.60%	-42.24%	-351.04%	-124.08%	-91.95%
Return on Assets (ROA)	-9.55%	0.82%	-15.24%	-10.09%	-42.02%	-44.92%
Return on Capital (ROIC)	-11.39%	1.22%	-22.00%	-12.30%	-47.83%	-56.15%
Return on Capital Employed (ROCE)	-16.80%	1.50%	-37.70%	-16.70%	-80.60%	-50.30%
Earnings Yield	-12.64%	0.91%	-20.12%	-323.08%	-54.15%	-57.73%
FCF Yield	1.27%	-6.94%	-	-17.63%	-28.78%	-46.51%
Buyback Yield / Dilution	-35.31%	-52.28%	-1295.73%	-191.14%	-86.97%	-589.05%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.